L'intérêt à découvert pour Marsh & McLennan Cos donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Marsh & McLennan Cos. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Marsh & McLennan Cos (NYSE:MMC) Stock, Rapport sur les intérêts à découvert

Marsh & McLennan

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Companies Inc

NYLI MacKay California Muni Intermediate ETF

Members Co Ltd

MAG MILE CAPITAL,INC by Mag Mile Capital Inc.

Mag Mile Capital Inc

Andean Silver Ltd

Mind Medicine Inc Warrants(11/12/2023)

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and lowers the price target from $220 to $215.

News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan Cos, Lowers Price Target to $215

Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 20 years by 6.83% on an annualized basis producing an average annual return of 14.73%. Currently, Marsh &amp; McLennan Cos has a market capitalization of $108.47 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 20 years ago, it would be worth $1,560.78 today based on a price of $220.07 for MMC at the time of writing.
<h3>Marsh &amp; McLennan Cos's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745019912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Wall Street saw a rebound in risk appetite on Thursday ahead of the long Easter weekend, as President Donald Trump signaled positive <a href="https://www.benzinga.com/topic/donald-trump">momentum in trade negotiations.</a>
Speaking ahead of a scheduled meeting with Italian Prime Minister Giorgia Meloni, Trump expressed strong confidence in reaching a trade agreement with the European Union. He also hinted at progress with China, stating, "We will make a good deal with China." 
Meanwhile, U.S. Treasury Secretary Scott Bessent noted that trade talks with Japan are moving in a highly satisfactory direction.
By midday in New York, the S&amp;P 500 had climbed 0.9%, while the Nasdaq 100 gained 0.5%, recouping some losses after a 3% slide on Wednesday. The Dow Jones, however, slipped 0.9%, weighed down by a sharp 23% plunge in UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) after the company slashed its full-year earnings forecast.
Energy stocks led the day&#8217;s gains, buoyed by rising oil prices. Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) rallied 4.1%, while Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) advanced 3.5%.
Gold prices retreated nearly 1% after a strong multi-day rally, pressured by a firmer U.S. dollar and rising Treasury yields. The 10-year Treasury yield climbed six basis points to 4.34%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged up 0.9% to $85,000.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg (%)</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,884.35</td>
<td>1.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,323.43</td>
<td>0.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,357.77</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,441.72</td>
<td colspan="2">-0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.8% to $530.09.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.7% to $394.05.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.5% to $446.19.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 1% to $186.67.</li>
<li>The&nbsp;Energt&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 3.5%; the&nbsp;Health Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 0.1%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Eli Lilly Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) surged 16% after announcing that its oral GLP-1 receptor agonist, Orforglipron, successfully completed Phase 3 trials without requiring food or water restrictions.</li>
<li>Fidelity National Information Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) jumped 9% after announcing a $13.5 billion deal to acquire Global Payments Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>)&#8217;s Issuer Solutions business. The move is aimed at bolstering FIS's fintech capabilities and is expected to generate over $125 million in annual revenue synergies. Shares of GPN tumbled 15%. </li>
<li>Companies reacting to earnings reports included American Express Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), up 0.5%; Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), up 1.9%; Charles Schwab Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>), up 2.7%; Marsh &amp; McLennan Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) down 3.3%; Truist Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>), up 1.3%; State Street Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>), up 3.2%; KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>), up 3.7% and Huntington Bancshares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>), up 4%.</li>
<li>Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) rose 2% ahead of the earnings report, which is slated for release after the market close. </li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable">UnitedHealth CEO Says High Cost Of US Health Care &#8216;Simply Not Sustainable&#8217;</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Economics

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

HBAN

NFLX

SCHW

Wall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What's Driving Markets Thursday?

WIIM

Marsh & McLennan shares are trading lower after the company reported worse-than-expected Q1 revenue results.

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) reported quarterly earnings of $3.06 per share which beat the analyst consensus estimate of $3.02 by 1.32 percent. This is a 4.79 percent increase over earnings of $2.92 per share from the same period last year. The company reported quarterly sales of $7.06 billion which missed the analyst consensus estimate of $7.08 billion by 0.31 percent. This is a 9.08 percent increase over sales of $6.47 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Marsh & McLennan Q1 Adj EPS $3.06 Beats $3.02 Estimate, Sales $7.06B Miss $7.08B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $250.69 million. 
• Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is expected to report quarterly earnings at $1.82 per share on revenue of $23.92 billion. 
• Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) is expected to report quarterly earnings at $1.05 per share on revenue of $220.76 million. 
• Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) is estimated to report quarterly earnings at $1.01 per share on revenue of $5.54 billion. 
• Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.97 billion. 
• ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $3.96 billion. 
• State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) is likely to report quarterly earnings at $2.01 per share on revenue of $3.32 billion. 
• American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) is expected to report quarterly earnings at $3.47 per share on revenue of $16.93 billion. 
• Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) is estimated to report quarterly earnings at $3.00 per share on revenue of $7.08 billion. 
• D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) is estimated to report quarterly earnings at $2.65 per share on revenue of $8.03 billion. 
• Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) is projected to report quarterly earnings at $4.82 per share on revenue of $1.21 billion. 
• Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) is likely to report quarterly earnings at $0.73 per share on revenue of $363.15 million. 
• Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) is expected to report quarterly earnings at $0.70 per share on revenue of $2.16 billion. 
• Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) is estimated to report quarterly earnings at $0.95 per share on revenue of $283.30 million. 
• Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) is likely to report quarterly earnings at $0.51 per share on revenue of $1.83 billion. 
• Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $2.68 billion. 
• Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $4.94 billion. 
• UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) is likely to report quarterly earnings at $7.29 per share on revenue of $111.60 billion. 
• Insteel Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIIN#NYSE">IIIN</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $149.85 million. 
• Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $101.16 million. 
• Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) is estimated to report quarterly earnings at $0.31 per share on revenue of $1.89 billion. 
• Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $4.90 billion. 
• KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $1.75 billion. 
<h3>Companies Reporting After The Bell</h3>
• Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is expected to report quarterly earnings at $5.72 per share on revenue of $10.51 billion. 
• Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) is expected to report quarterly earnings at $1.16 per share on revenue of $175.04 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLY

FITB

HOFT

IIIN

INDB

INFY

TCBI

Earnings Scheduled For April 17, 2025

In the current session, the stock is trading at $233.91, after a 0.67% increase. Over the past month, Marsh &amp; McLennan Cos Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) stock increased by 1.03%, and in the past year, by 16.47%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1744819229_0.png" alt="Past Year Chart" />

<h3>Evaluating Marsh &amp; McLennan Cos P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 62.22 in the Insurance industry, Marsh &amp; McLennan Cos Inc. has a lower P/E ratio of 28.41. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744819229_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Marsh & McLennan Cos

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) is preparing to release its quarterly earnings on Thursday, 2025-04-17. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Marsh &amp; McLennan to report an earnings per share (EPS) of $3.09.
The announcement from Marsh &amp; McLennan is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.11, leading to a 1.79% drop in the share price the following trading session.
Here's a look at Marsh &amp; McLennan's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.76</td>
<td>1.61</td>
<td>2.40</td>
<td>2.80</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.87</td>
<td>1.63</td>
<td>2.41</td>
<td>2.89</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744812084_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Marsh &amp; McLennan were trading at $232.36 as of April 15. Over the last 52-week period, shares are up 15.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Marsh &amp; McLennan</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Marsh &amp; McLennan.
With 8 analyst ratings, Marsh &amp; McLennan has a consensus rating of Neutral. The average one-year price target is $236.12, indicating a potential 1.62% upside.
<h3>Peer Ratings Overview</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Arthur J. Gallagher, Aon and Brown &amp; Brown, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Arthur J. Gallagher, with an average 1-year price target of $324.1, suggesting a potential 39.48% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Aon, with an average 1-year price target of $414.0, suggesting a potential 78.17% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Brown &amp; Brown, with an average 1-year price target of $120.0, suggesting a potential 48.36% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Arthur J. Gallagher, Aon and Brown &amp; Brown are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marsh &amp; McLennan Cos</td>
<td>Neutral</td>
<td>9.24%</td>
<td>$2.44B</td>
<td>5.83%</td>
</tr>
<tr>
<td>Arthur J. Gallagher</td>
<td>Neutral</td>
<td>11.68%</td>
<td>$1.13B</td>
<td>1.60%</td>
</tr>
<tr>
<td>Aon</td>
<td>Outperform</td>
<td>22.87%</td>
<td>$2.03B</td>
<td>11.58%</td>
</tr>
<tr>
<td>Brown &amp; Brown</td>
<td>Neutral</td>
<td>12.04%</td>
<td>$506M</td>
<td>3.21%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Marsh &amp; McLennan ranks in the middle among its peers for Consensus rating. It is at the bottom for Revenue Growth and Gross Profit, while it is at the top for Return on Equity.
<h3>About Marsh &amp; McLennan</h3>
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
<h3>Marsh &amp; McLennan's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Marsh &amp; McLennan showcased positive performance, achieving a revenue growth rate of 9.24% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Marsh &amp; McLennan's net margin excels beyond industry benchmarks, reaching 12.99%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Marsh &amp; McLennan's ROE excels beyond industry benchmarks, reaching 5.83%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Marsh &amp; McLennan's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.48% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Marsh &amp; McLennan's debt-to-equity ratio is below the industry average at 1.64, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/MMC/earnings">To track all earnings releases for Marsh &amp; McLennan visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: Marsh & McLennan's Quarterly Earnings

Marsh &amp; McLennan Cos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has fallen 27.42% since its last report. The company recently reported that it has 4.43 million shares sold short, which is 0.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Cos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744729230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan Cos has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Marsh &amp; McLennan Cos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Marsh &amp; McLennan Cos's peer group average for short interest as a percentage of float is 2.54%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Marsh & McLennan Cos?

Barclays analyst Alex Scott maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and raises the price target from $246 to $249.

Barclays Maintains Equal-Weight on Marsh & McLennan Cos, Raises Price Target to $249

Jefferies analyst Yaron Kinar maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Hold and raises the price target from $237 to $244.

Jefferies Maintains Hold on Marsh & McLennan Cos, Raises Price Target to $244

Wells Fargo analyst Elyse Greenspan maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and raises the price target from $223 to $232.

Wells Fargo Maintains Equal-Weight on Marsh & McLennan Cos, Raises Price Target to $232

Brighthouse Financial, Inc. - Common Stock

BWIN

CINF

ERIE

GSHD

HUIZ

ITIC

KMPR

KNSL

LMND

OSCR

PLMR

ROOT

RYAN

SKWD

TRUP

TWFG

ZBAO

Shares of insurance companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

UBS analyst Brian Meredith maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Buy and raises the price target from $259 to $261.

UBS Maintains Buy on Marsh & McLennan Cos, Raises Price Target to $261

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and raises the price target from $210 to $220.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan Cos, Raises Price Target to $220

U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following President Donald Trump&#8216;s 104% tariff on China. Futures of major benchmark indices were mixed in premarket.
The White House Press Secretary Karoline Leavitt <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44698697/markets-reverse-gains-as-trumps-104-china-tariff-announcement-rattles-wall-street">confirmed that Trump&#8217;s retaliatory</a> 104% tariff on Chinese imports would take effect at 12:01 a.m. ET Wednesday. Her remarks triggered a sharp deterioration in market sentiment and reignited fears of a global trade escalation.
Despite growing geopolitical concerns surrounding China, a new U.S. Chamber of Commerce Foundation <a href="https://www.benzinga.com/news/global/25/04/44700937/us-companies-stick-with-china-as-trump-tariffs-take-effect-report">report highlighted by</a> The Wall Street Journal reveals that most surveyed companies still find significant strategic advantages in staying or growing their operations there.
This finding underscores a divergence between Washington&#8217;s &#8220;selective decoupling&#8221; efforts and the deep reliance of corporate America on China&#8217;s manufacturing, workforce, and consumer base.
Major indices were significantly down from recent highs as of Tuesday&#8217;s close. The S&amp;P 500 was 18.95% lower, the Nasdaq 100 was down 23.10%, and the Dow Jones declined 16.48%, following a week of tariff-driven selloffs.
The 10-year Treasury bond yielded 4.35% and the two-year bond was at 3.80%. However, the CME Group's FedWatch&nbsp;<a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>‘s projections showed markets pricing a 58.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.06%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.22%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.64%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.17%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.30% to $497.98, while the QQQ advanced 0.63% to $418.70, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Consumer discretionary, materials, and energy sectors led a broad decline in U.S. stocks on Tuesday, as the S&amp;P 500 closed entirely in negative territory.
The selloff intensified after the President&#8217;s 104% tariff.
Among individual tech giants, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) saw significant drops, while Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) also traded lower.
In other news, Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reported better-than-expected earnings, and small business optimism hit its lowest point since October 2024.
The Dow Jones index slumped 320 points or 0.84% to 37,645.59, whereas the S&amp;P 500 index fell 1.57% to 4,982.77. Nasdaq Composite declined to end 2.15% lower at 15,267.91, and the small-cap gauge, Russell 2000, tumbled 2.73% to 1,760.71.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.15%</td>
<td>15,267.91</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.57%</td>
<td>4,982.77</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.84%</td>
<td>37,645.59</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.73%</td>
<td>1,760.71</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
In this environment of heightened uncertainty, Julia Khandoshko, CEO at European broker Mind Money, advises investors to focus on capital preservation rather than chasing high returns.
&#8220;The most rational strategy in the short term is to focus on liquidity, reliable fixed-income instruments, and safe haven assets such as gold. This is not an attempt to make money but a need to preserve capital in conditions of high uncertainty,&#8221; she adds.
Even nations currently enjoying a trade surplus shouldn&#8217;t be complacent, warns Khandoshko. She points to the danger of stagflation – a damaging combination of stalled economic growth and ongoing inflation – using Japan&#8217;s long-lasting difficulties as a stark example.
The widening 3-year SOFR swap spread is signaling <a href="https://www.benzinga.com/government/regulations/25/04/44705659/cathie-wood-points-to-serious-liquidity-issues-as-overnight-borrowing-rate-spreads-widen-o">growing liquidity problems</a> within the U.S. banking system, according to Ark Invest CEO Cathie Wood. She argues that this crisis necessitates swift solutions, including a trade agreement and aggressive Federal Reserve intervention, emphasizing the urgency with &#8220;No more time to waste.&#8221;
This spread, a key indicator of U.S. banking liquidity, represents the difference between the fixed rate in a SOFR-based swap and the yield on a government bond of the same maturity.
SOFR, the Secured Overnight Financing Rate, is the benchmark reflecting the cost of overnight cash borrowing used across various financial transactions, and its widening spread adds to existing concerns about emerging liquidity issues in the U.S. market.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As Zerohedge notes, this swap spread is suggesting serious liquidity issues in the US banking system. This crisis is calling out for some kind of Mar-a-Lago Accord on free trade, in tandem with serious support from the Fed? No more time to waste. <a href="https://t.co/5VXYqLJemJ">https://t.co/5VXYqLJemJ</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1909816910033678801?ref_src=twsrc%5Etfw">April 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Ed Yardeni of Yardeni Research suggests that "Fixed-income investors may be starting to worry that the Chinese and other foreigners might start selling their U.S. Treasuries," after Trump levied 104% tariff duties on China after the latter's retaliation.
Adding to the market unease, credit markets are exhibiting increasing strain, evidenced by a rapidly widening yield spread between high-yield corporate bonds and the 10-year Treasury.
Data from Yardeni indicates this spread reached 407 basis points as of April 7th, signaling declining investor confidence and growing concerns about an economic slowdown or potential recession.
"The good news is that the Fed Put will probably make a quick comeback if this happens," said Yardeni.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul>
<li>February&#8217;s wholesale inventories data will be released by 10:00 a.m., and Richmond Fed President Tom Barkin will speak at 11:00 a.m. ET.</li>
</ul>
<ul>
<li>Minutes of Fed&#8217;s March FOMC meeting will be out by 2:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) declined 1.11% in premarket on Tuesday before the opening bell. Analysts expect a quarterly earnings of 38 cents per share on revenue of $13.02 billion.</li>
<li>Simply Good Foods Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) was up 1.45% as Wall Street expects it to report earnings of 40 cents per share on revenue of $354.43 million before the opening bell.</li>
<li>Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) was down 1.10% ahead of its earnings call after the closing bell. Analysts expect a quarterly earnings of $2.28 per share on revenue of $2.13 billion.</li>
<li>Kura Sushi USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) dropped 3.28% after posting downbeat results for its second quarter. The company also said it sees FY25 total sales of $275 million to $279 million, versus market estimates of $280.741 million.</li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) climbed 1.92% after posting better-than-expected earnings and sales results for its third quarter on Tuesday.</li>
<li>Redwire Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) was 2.98% higher after it announced to jointly pursue commercial lunar missions with ispace U.S., including NASA CLPS, leveraging Redwire&#8217;s space infrastructure and ispace U.S.&#8217;s lunar transportation.</li>
<li>Marsh &amp; McLennan Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) jumped 17.83% as it announced the acquisition of Arthur Hall Insurance on April 2.</li>
<li>Vincerx Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) plunged 52.39% after disclosing that it has terminated the previously announced non-binding Letter of Intent with Global Digital Holdings regarding a potential merger.</li>
<li>Cartesian Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) tumbled 36.97% after reporting 12-month data for lead cell therapy in myasthenia gravis patients.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 2.59% to hover around $57.82 per barrel.
Gold Spot US Dollar advanced 2.04% to hover around $3,043.09 per ounce. Its fresh record high stood at $3,168.04 per ounce. The U.S. Dollar Index spot was lower by 0.49% at the 102.450 level.
Asian markets were mostly lower on Wednesday. Except for China&#8217;s CSI 300 and Hong Kong's Hang Seng index, India's S&amp;P BSE Sensex, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index declined. European markets were also lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44705659/cathie-wood-points-to-serious-liquidity-issues-as-overnight-borrowing-rate-spreads-widen-on-spiking-treasury-yields-this-crisis-is-calling-out-for-some-kind-of-mar-a-lago-accord">Cathie Wood Points To &#8216;Serious Liquidity Issues&#8217; As Overnight Borrowing Rate Spreads Widen On Spiking Treasury Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Futures

Federal Reserve

Pre-Market Outlook

AAPL

AEHR

AMZN

KRUS

NVDA

RNAC

SMPL

TSLA

VINC

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert

Shares of Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) rose sharply in today's pre-market trading after the company announced it secured $23.24 million in bridge financing from <a href="https://www.benzinga.com/quote/vero">Madryn Health Partners</a>.
Venus Concept shares jumped 201% to $8.67 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Femto Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMTO#NASDAQ">FMTO</a>) rose 95.7% to $5.50 in pre-market trading after gaining around 390% on Tuesday.</li>
<li>Scworx Corp (NASDA: WORX) rose 70.8% to $1.36 in pre-market trading after gaining 7% on Tuesday.</li>
<li>Flushing Financial Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) surged 53.1% to $17.00 in pre-market trading.</li>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) gained 37.1% to $0.73 in pre-market.</li>
<li>Webster Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBS#NYSE">WBS</a>) rose 36.4% to $56.99 in pre-market trading.</li>
<li>Antelope Enterprise Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) rose 30.6% to $2.85 in pre-market trading after dipping over 15% on Tuesday.</li>
<li>Viper Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) gained 25.7% to $46.00 in pre-market trading.</li>
<li>Bit Origin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) gained 23.7% to $0.18 in pre-market trading after gaining 22% on Tuesday.</li>
<li>Marsh &amp; McLennan Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) surged 17.8% to $260.00 in pre-market trading. On April 2, Marsh McLennan Agency announced the acquisition of Arthur Hall Insurance.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Vincerx Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) fell 54.1% to $0.25 in pre-market trading. Vincerx Pharma disclosed that it has terminated previously announced non-binding Letter of Intent with Global Digital Holdings regarding a potential merger.</li>
<li>Cartesian Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) shares tumbled 37% to $6.00 in pre-market trading. Cartesian Therapeutics, on Tuesday, reported 12-month data for lead cell therapy in myasthenia gravis patients.</li>
<li>Enhabit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) fell 35.5% to $5.00 in today's pre-market trading.</li>
<li>CCC Intelligent Solutions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCS#NASDAQ">CCCS</a>) shares dipped 34.8% to $5.40 in pre-market trading.</li>
<li>Smith Douglas Homes Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDHC#NYSE">SDHC</a>) fell 32.5% to $12.00 in pre-market trading after dipping 10% on Tuesday.</li>
<li>Incannex Healthcare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) shares fell 29% to $0.60 in pre-market trading after surging 70% on Tuesday.</li>
<li>SaverOne 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares fell 28.2% to $2.59 in pre-market trading after gaining 11% on Tuesday.</li>
<li>Donegal Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGICA#NASDAQ">DGICA</a>) fell 27.3% to $13.10 in pre-market trading. Donegal Group will release its results for first quarter on Thursday, April 24, before the opening bell.</li>
<li>Ambac Financial Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) declined 24.1% to $5.00 in pre-market trading.</li>
<li>LXP Industrial Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXP#NYSE">LXP</a>) dipped 17.7% to $5.94 in pre-market trading. LXP Industrial Trust will release its first quarter financial results on Thursday, May 1.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

AEHL

AMBC

BTOG

CCCS

DGICA

EHAB

FFIC

FMTO

IXHL

SDHC

SVRE

TNMG

VERO

VNOM

WORX

Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket

Marsh McLennan Agency (MMA), a business of Marsh and a leading provider of business insurance, employee health and benefits, retirement and wealth, and private client insurance solutions across the US and Canada, today announced the acquisition of Arthur Hall Insurance, a West Chester, Pennsylvania-based full-service insurance agency. Terms of the acquisition were not disclosed.
Founded in 1966, Arthur Hall provides commercial and personal lines expertise to clients across the country, with specialties in the life sciences, information management, non-profit, craft beverage manufacturing, and municipal industries. All Arthur Hall employees, including President Jim Denham, will join MMA and continue to operate out of their two office locations in West Chester and Wilmington, Delaware.
"Our clients are facing challenges on multiple fronts, and our value lies in the ability to foresee these dynamics and equip them for any scenario," said Andrew Neary, CEO of MMA's East region. "We look forward to bringing the Arthur Hall team's business insurance expertise to our clients in the region, while simultaneously establishing a new presence for MMA in Delaware."
Mr. Denham added: "MMA has a unique power of perspective that is unmatched in the industry. In our ongoing pursuit of enhancing client outcomes, it became clear that joining MMA was our best path forward for our clients and colleagues, providing access to a wide range of risk mitigation strategies and a network of experts for clients and resources to enhance our colleagues' careers."

Marsh McLennan Agency Acquires Arthur Hall Insurance; Terms Not Disclosed

Marsh &amp; McLennan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has risen 3.88% since its last report. The company recently reported that it has 5.42 million shares sold short, which is 1.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742916622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Marsh &amp; McLennan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Marsh &amp; McLennan's peer group average for short interest as a percentage of float is 2.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Marsh & McLennan Gaining or Losing Market Support?

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 20 years by 6.49% on an annualized basis producing an average annual return of 14.71%. Currently, Marsh &amp; McLennan has a market capitalization of $114.62 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 20 years ago, it would be worth $1,555.80 today based on a price of $233.37 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742503514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Press Releases

Despite Economic Uncertainty, US Employers Maintain Elevated Compensation Budgets for 2025, According to Mercer

Marsh McLennan Agency Acquires Acumen Solutions Group

Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30

Marsh McLennan Declares Quarterly Cash Dividend

Marsh McLennan Reports Strong Fourth Quarter and Full-Year 2024 Results

Marsh McLennan's Mercer to Acquire SECOR Asset Management

Marsh McLennan to Host First Quarter Earnings Investor Call on April 17

Marsh McLennan Agency Acquires Arthur Hall Insurance

Marsh McLennan Reports First Quarter 2025 Results

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

AIFU

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Marsh & McLennan Cos

Intérêt court

Marsh & McLennan Cos (NYSE:MMC) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL